Bharat Biotech expects EUA from WHO for Covaxin in July- September

By: |
May 25, 2021 7:59 PM

The company said regulatory approvals for Covaxin are in process in more than 60 countries including the USA, Brazil and Hungary among others.

covaxinThe company said regulatory approvals for Covaxin are in process in more than 60 countries.

Bharat Biotech on Tuesday said it expects approval for its COVID-19 vaccine Covaxin from the World Health Organisation for Emergency Use Authorisation during July-September.

The company said regulatory approvals for Covaxin are in process in more than 60 countries including the USA, Brazil and Hungary among others.

“Application for EUL has been submitted to WHO-Geneva, regulatory approvals are expected July-September 2021,” it said in a release.

The city based vaccine maker said it has got EUA in 13 countries with more to follow.

Most countries recommend vaccinations against COVID-19.

Unvaccinated travelers can travel with negative RT-PCR tests prior to travel, in the absence of any other country specific travel restrictions, Bharat Biotech said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Delta variant constitutes over 6% of tested Covid cases with virus variants in NYC: Health dept
2Covid-19: Centre tells states to aggregate vaccine demand from private sector
3Third wave of Covid-19 may not hit children as feared: VK Paul, member, health, Niti Aayog